Stay updated on ARCHES-2 Study: ARO-ANG3 Clinical Trial

Sign up to get notified when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARCHES-2 Study: ARO-ANG3 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows a new site revision note: Revision: v3.4.2 was added, with v3.4.1 retained for context. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T05:51:33.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status with a link to opm.gov for updates. Updated the site revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T04:40:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary is now shown by default, and QA metadata such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted' are displayed with a new 'Revision: v3.4.0' banner. The No FEAR Act Data label was added and the previous 'No FEAR Act data' label and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T03:09:29.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the page and Revision: v3.3.3 was removed. This appears to be a minor metadata update that does not modify the study details, endpoints, or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-01-14T01:21:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a comprehensive list of study locations across multiple regions (California, Florida, Minnesota, Nebraska, Nevada, New York, North Carolina, Ohio, Pennsylvania, Texas; New South Wales, Queensland; Ontario, Quebec) under Locations. Updated the revision tag from v3.3.2 to v3.3.3 and removed the prior version indicator.
    Difference
    1%
    Check dated 2025-12-23T09:18:27.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The ARCHES-2 study record adds many new research sites worldwide and updates open-label extension timepoints and additional lipid endpoints.
    Difference
    2%
    Check dated 2025-12-08T23:06:16.000Z thumbnail image

Stay in the know with updates to ARCHES-2 Study: ARO-ANG3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.